Pharmaceutical Management Agency

COVID-19 Early Treatment Options - where are they?

Response by Pharmaceutical Management Agency to Micky Turner on January 17, 2022.

Successful.

Tēnā koe Micky Pharmac is continuing to evaluate potential treatments for COVID-19 as evidence emerges. We are happy to consider funding a...

Remdesivir costs $4400 per person - Covid 19: European study finds no clinical benefit

Request to Pharmaceutical Management Agency by Micky Turner. Annotated by Virginia Crawford on December 17, 2021.

Successful.

According to the reply to a recent OIA request, 25 people were treated with Remdesivir in Auckland during the recent outbreak (there may be more since...

Why have you restricted Ivermectin?

Response by Pharmaceutical Management Agency to Annie Weston on September 20, 2021.

Successful.

Mōrena Annie Please find attached a response to your further correspondence regarding ivermectin. Ngā mihi Melody Willis (she/her) | Government Ser...

Information regarding Dexcom CGMS and Libre FGMS

Response by Pharmaceutical Management Agency to D Smith on March 26, 2021.

Awaiting classification.

Kia ora D Smith Further to our previous email to you on Friday 19 March 2021, please find attached the final response to your request for inform...

Cost of PreP since funding began in 2018

Response by Pharmaceutical Management Agency to Elliot Ikilei on February 05, 2021.

Successful.

Kia ora Elliot Please find attached a response to your request for information received by PHARMAC on 6 January 2021. Please feel free to...

Cost of funding Tramadol in 2019

Response by Pharmaceutical Management Agency to Brianna Stewart on September 03, 2020.

Successful.

Kia ora Brianna Please find the response to your OIA 2020-21-020 dated 18 August 2020 regarding tramadol funding for calendar year 2019. N...

PTAC subcommittees- OIA request

Response by Pharmaceutical Management Agency to john luke on August 10, 2020.

Successful.

Kia ora John Please find attached to this email a response to your OIA request 2020-21-015 dated 14 July 2020. Ngā mihi Melody W...

Discontinuation of Phenelzine Sulphare

Response by Pharmaceutical Management Agency to Megs on June 19, 2020.

Successful.

Dear Megs Attached is PHARMAC's response to your recent information request. Kind regards PHARMAC | Te Pātaka Whaioranga | PO Box 10 254 | Level 9,...

Rationale for defunding of Androderm 2.5mg Patches

Response by Pharmaceutical Management Agency to Scout Barbour-Evans on June 11, 2019.

Successful.

Hello Scout Androderm 2.5mg patches were delisted from the Pharmaceutical Schedule from 1 March 2018. In October 2016, the manufacturers proposed del...

Consumer Advisory Committee (CAC)

Response by Pharmaceutical Management Agency to john luke on April 23, 2020.

Successful.

Good afternoon John Please find attached PHARMAC's response to your recent request for information about CAC membership. Kind regards, Susan Susan...

Shortage of Phenelzine sulphate

Response by Pharmaceutical Management Agency to Megs on October 14, 2019.

Successful.

Dear Megs Please find attached a letter and related documents related to your request for information about phenelzine supply. Kind regards Simon E...

Supporting/supplementary documentation to the 1 & 2 November 2018 PTAC minutes on funding of Whole Thyroid Extract and Liothyronine

Response by Pharmaceutical Management Agency to Belinda Hodson on April 07, 2020.

Awaiting classification.

Good morning Belinda Please find attached PHARMAC's response to your recent request for information about the funding of Whole Thyroid Extract and Lio...

Citation list for PHARMAC funded thyroid medications and patient survey data

Response by Pharmaceutical Management Agency to Belinda Hodson on February 24, 2020.

Partially successful.

Dear Belinda Please find attached further correspondence in relation to your request for information about thyroid medications (OIA reference 2019-20-...

Approval of PHARMAC funded thyroid medications

Response by Pharmaceutical Management Agency to Belinda Hodson on January 24, 2020.

Partially successful.

Good afternoon Belinda. Please find attached our response to your request for PTAC minutes and the Endocrinology Subcommittee minutes that recommended...

PrEP Correspondence

Response by Pharmaceutical Management Agency to Gemma Crawley on October 08, 2019.

Information not held.

Dear Gemma Please find attached a response to your request for information about PREP correspondence Kind regards Simon England | Se...

Pharmac Funding Applications

Response by Pharmaceutical Management Agency to Gemma Crawley on July 31, 2019.

Successful.

Hi Gemma Most of the funding applications we receive come from suppliers. NZAF did apply to us for PrEP. And the Breast Cancer Aotearoa Coalition appl...

PrEP

Response by Pharmaceutical Management Agency to Gemma Crawley on June 04, 2019.

Partially successful.

Hi Gemma apologies the wrong link, Vikki https://www.pharmac.govt.nz/news/notification-2018-02-07-prep/

Vanlafaxine - Bioavailability studies

Response by Pharmaceutical Management Agency to R Whyte on June 13, 2019.

Awaiting classification.

Dear Mt Whyte Please find attached a response to you and the information requested. Kind regards Donna Jennings PHARMAC 10 Jun...

Consumer Advisory Committee

Response by Pharmaceutical Management Agency to john luke on May 30, 2019.

Successful.

Hello John I am replying on behalf of Katie. The member's term of appointment is for up to three years. You can express an interest by contacting [e...

People using PrEP contracting HIV

Response by Pharmaceutical Management Agency to The Magic Roast on April 26, 2019.

Awaiting classification.

Hi Jacky, huge apologies! Here is our response. Have a lovely weekend Jane Jacky Thorndon [FOI #9905 email] 26 April 2019 Dear Jacky, REQUEST FOR I...

List of most most costly and most prescribed medications

Response by Pharmaceutical Management Agency to Sam Wagener on January 23, 2019.

Refused.

Dear Mr Wagener Please find attached a letter regarding your request for official information. Yours sincerely Ministerial Support Services [em...

Cost of funding PrEP

Response by Pharmaceutical Management Agency to Felix Swadel on November 01, 2018.

Awaiting classification.

Hi Felix Please see attached the response to your OIA request. Kind regards Dean PHARMAC 1 November 2018 Felix Swadel Via email:...

Arrow Venlafaxine needs to come back under NZ funding.

Response by Pharmaceutical Management Agency to VICKI CAREY on September 25, 2018.

Partially successful.

Kia ora Vicki Thank you for your enquiry. You have asked why the Arrow-Venlafaxine XR and Efexor XR brands were removed when it was doing good f...

Arrow Venlafaxine

Response by Pharmaceutical Management Agency to Trudi Webber on August 02, 2018.

Successful.

Dear Trudi Thank you for your query regarding the initial listing date for Arrow-Venlafaxine XR tablets in the Pharmaceutical Schedule. Ar...

Who did the research that was used to compare Enlafax with other brands?

Response by Pharmaceutical Management Agency to Trudi Webber on May 24, 2018.

Successful.

Dear Ms Webber, Kindly note the Ministry is awaiting your clarification please on your request. Kind regards Maima Ministerial Services (OIA) [...

FYI

(page 2)

More about this authority